CLIMB BIO INC (CLYM) — institutional ownership

117 funds reported holding CLIMB BIO INC in their latest 13F filings, worth $743M in total (CUSIP 28658R106).

Largest holders

1. RA CAPITAL MANAGEMENT, L.P. — $147M
2. FMR LLC — $88.5M
3. UBS Group AG (UBS) — $44.4M
4. BRAIDWELL LP — $36.5M
5. ADAGE CAPITAL PARTNERS GP, L.L.C. — $32.7M
6. BlackRock, Inc. (BLK) — $30.7M
7. PRICE T ROWE ASSOCIATES INC /MD/ — $27.7M
8. Cormorant Asset Management, LP — $27.5M
9. FRONTIER CAPITAL MANAGEMENT CO LLC — $25.3M
10. VANGUARD CAPITAL MANAGEMENT LLC — $22.2M

Famous investors holding it

• Ken Griffin portfolio (Citadel Advisors)
• Izzy Englander portfolio (Millennium Management)
• Renaissance Technologies portfolio (Renaissance Technologies)
• Two Sigma portfolio (Two Sigma Investments)
• D. E. Shaw portfolio (D. E. Shaw & Co.)

Insider buying and selling at CLIMB BIO INC

Who owns the most CLYM stock?

The largest institutional holders in the latest 13F filings are RA CAPITAL MANAGEMENT, L.P. ($147M), FMR LLC ($88.5M), UBS Group AG (UBS) ($44.4M).

How many funds own CLYM?

117 funds reported holding it, worth $743M in total.